Roche shares drop after deaths of patients taking Hemlibra

ZURICH (Reuters) - Swiss drugmaker Roche's shares dropped on Wednesday after it told U.S.-based haemophilia advocacy groups that five patients treated with its medicine Hemlibra had died, while maintaining that the therapy was not the cause of the deaths.

from Reuters: Health News https://ift.tt/2pQFg0P